Tag: Harm reduction | Page 4

Sharing the voices of people with lived experience on World Hepatitis Day

July 7, 2021 • By Conor Ashleigh, Nikitah Habraken and Christopher Hoy

Launched in 2019, the Connecting with Care films profile innovative models of hepatitis C care for people who use drugs in Toronto, Montreal and Ahtahkakoop First Nation. These films were a partnership between the International Network on Health and Hepatitis in Substance Users (INHSU), the Canadian Network on Hepatitis C (CanHepC) and CATIE. In a recent webinar, we reconnected with the people in these films to learn how they have adapted and responded to the needs of their community during COVID-19. Central to these films was the impact of people with lived experience in planning and delivering harm reduction and...

Connecting: A new resource for frontline harm reduction workers

June 14, 2021 • By Denise Beaumont

“I guess the term ‘quick reference’ is standing out in my mind, like something that’s very, very fast. Because if it’s too wordy I’m not going to have any time ─ something that is like a frequently asked questions kind of thing. A very quick and easy way to get the answer immediately, you know.” – frontline harm reduction worker in Ontario When frontline harm reduction staff were asked to describe the most effective resources to support them in their work with people who use drugs, they were clear about what they needed. The Best Practice Recommendations for Canadian Harm...

The elimination of viral hepatitis in Canada: Where are we now and where can we go?

May 20, 2021 • By Shannon Elliot

At the last Canadian Liver Meeting in 2020, there was a palpable sense of optimism about the prospect of eliminating hepatitis C in Canada. Researchers, service providers and community members launched a blueprint outlining our collective goals and possible strategies, and we shared evidence from research and practice to guide policy and programs. Then the COVID-19 pandemic happened. It had an enormous impact on our sector, with services scaled back, researchers and clinicians shifted to the COVID-19 response, and the communities most affected by hepatitis C also facing increased risks from COVID-19 and a growing overdose crisis.

COVID-19, curfews and the overdose crisis: A Quebec perspective

February 17, 2021 • By Frankie Lambert and Chantal Montmorency

To better understand the issues and priorities of people who use drugs in Quebec during the COVID-19 pandemic and the overdose crisis, CATIE conducted a short interview with Frankie Lambert and Chantal Montmorency, two staff members of the Quebec association to promote the health of people who use drugs (AQPSUD). Here are the concerns raised by their community.

Embracing next practices: Innovation during times of uncertainty

February 17, 2021 • By Shannon Elliot and Melisa Dickie

The emergence of the novel coronavirus disease (COVID-19) has disrupted the way we live and work. As evidence has continued to grow and evolve over the past 11 months, we have witnessed how quickly key messages and measures to reduce the transmission of the virus causing COVID-19 have changed. We have also seen how health and community services have adapted in the face of new challenges and many unknowns. This work to adapt in the face of so much disruption and uncertainty is challenging and a muscle that we are collectively using.

What topics in the CATIE Blog were top of mind in 2020?

December 21, 2020 • By Alexandra Murphy

The year 2020 will leave an indelible mark on our collective consciousness: across the world, people are confronted with the novel coronavirus disease (COVID-19) and it seems to have consumed our lives. For many of us, not a day goes by that we don’t think about the virus, how it has altered our daily activities and what we need to do for our communities to remain healthy. Since the virus hit Canada in March 2020, service providers from across the country have mobilized to keep their clients safe and provide them the care and services they need to prevent, test...